hiPSC-Driven Organoid Construction and Application Prospects
Regenerative Medicine and Dentistry · 21.03.2025 · 2 (1)
DOI: 10.53941/rmd.2025.100005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Regenerative Medicine and Dentistry, online erschienen am 21.03.2025. Verfasst von Bangheng Liu und 2 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Induced pluripotent stem cell (iPSC)-derived organoid platforms can simulate various target tissues and hold broad application prospects in personalized medicine, disease modeling, drug screening, organ transplantation, and understanding organ development mechanisms. Currently, the development of human iPSC (hiPSC) organoids is gradually shifting towards Matrigel-free and scaffold-free systems, promoting precise control over the composition and structure of these systems and establishing induction protocols for specialized organoids. Researchers are also exploring the construction of multifunctional systems with complex structures and material exchange channels through vascularization, segmented induction, and assembly technologies, though further breakthroughs are needed. In the future, hiPSC organoids are expected to advance towards personalized precision treatment, high-throughput module detection systems, multi-organ integration, and automation. Additionally, when combined with large artificial intelligence models, there is potential to establish hiPSC data and medical platforms, providing support for drug development and clinical decision-making. Moreover, the development of medical AI is anticipated to foster collaboration rather than competition, promoting coordinated growth in the field. For hiPSC-derived platforms, it is crucial to further enhance the ethical review framework to balance radical scientific exploration with conservative public attitudes. Researchers must also optimize or develop new induction protocols to reduce genomic instability and tumorigenic risks, while avoiding the emergence of non-target cells and insufficient functional maturity.
Zitieren
APA
Liu, B., Mu, Y., & Wang, D. (2025). hiPSC-Driven Organoid Construction and Application Prospects. Regenerative Medicine and Dentistry, 2(1). https://doi.org/10.53941/rmd.2025.100005
Vancouver
Liu B, Mu Y, Wang D. hiPSC-Driven Organoid Construction and Application Prospects. Regenerative Medicine and Dentistry. 2025;2(1). doi:10.53941/rmd.2025.100005
BibTeX
@article{Liu2025,
author = {Liu, Bangheng and Mu, Yulei and Wang, Dong-An},
title = {hiPSC-Driven Organoid Construction and Application Prospects},
journal = {Regenerative Medicine and Dentistry},
year = {2025},
volume = {2},
number = {1},
doi = {10.53941/rmd.2025.100005}
}
EUVIMED